What β-lactamases are, and why they matter
β-lactamases are bacterial enzymes that catalyse the breaking of the β-lactam ring — the chemical feature shared by penicillins, cephalosporins, carbapenems, and monobactams. Many bacterial species evolved β-lactamases as a defensive mechanism, and the result is that an antibiotic which 'should' work against an organism in the textbook can, in practice, be inactivated before it ever reaches its target.
The World Health Organization lists production as one of the major drivers of antimicrobial resistance globally, and Indian hospital antimicrobial stewardship programmes track β-lactamase patterns across local pathogens via susceptibility testing.
The inhibitor strategy
A β-lactamase inhibitor is a molecule designed to bind to the bacterial β-lactamase enzyme and neutralise it. Crucially, modern inhibitors have minimal direct antibacterial activity on their own — their job is to protect the partner antibiotic in the same vial.
Clavulanic acid was the first widely-used inhibitor (paired with amoxicillin). Sulbactam came next, typically paired with ampicillin, cefoperazone, or ceftriaxone. Tazobactam was developed for use with piperacillin, then later cefepime and ceftolozane. Each inhibitor has a slightly different spectrum of β-lactamases it can neutralise — which is why ceftriaxone-sulbactam, ceftriaxone-tazobactam, and piperacillin-tazobactam are clinically distinct products and not interchangeable.
Reading combination strengths
Combination antibiotic vials are labelled with the strengths of both molecules — typically the active antibiotic listed first and the inhibitor second. '1 g + 500 mg' on a cefoperazone-sulbactam label means 1 g of cefoperazone plus 500 mg of sulbactam. The 'total' figure that sometimes appears on packaging (e.g. '1.5 g') is the sum of both — useful for understanding the powder mass to be reconstituted, but not the dose of either active alone.
ALTRAVAX's catalogue lists every combination ratio explicitly so procurement teams can match exactly to the prescriber's order without ambiguity.
Sources
Disclaimer: Articles in the Knowledge Centre are educational. They do not constitute prescribing information, medical advice, or product promotion. Always refer to the Indian Pharmacopoeia and consult a Registered Medical Practitioner for clinical decisions.